Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study

Breath testing is becoming an important diagnostic method to evaluate many disease states. In the light of rising healthcare costs, is important to develop a simple non‐invasive tool to potentially identify paediatric patients who need endoscopy for suspected inflammatory bowel disease (IBD).

[1]  C Harmston,et al.  Review article: next generation diagnostic modalities in gastroenterology – gas phase volatile compound biomarker detection , 2014, Alimentary pharmacology & therapeutics.

[2]  David Smith,et al.  Mass spectrometry for real-time quantitative breath analysis , 2014, Journal of breath research.

[3]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[4]  Patrik Španěl,et al.  Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry. , 2013, Rapid communications in mass spectrometry : RCM.

[5]  Conrad Bessant,et al.  Analysis of Volatile Organic Compounds of Bacterial Origin in Chronic Gastrointestinal Diseases , 2013, Inflammatory bowel diseases.

[6]  G. Hanna,et al.  Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. , 2013, Analytical chemistry.

[7]  Raed A Dweik,et al.  Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure. , 2013, Journal of the American College of Cardiology.

[8]  James A. Covington,et al.  A Novel Tool for Noninvasive Diagnosis and Tracking of Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[9]  P. X. Braun,et al.  Bridging the Collaborative Gap: Realizing the Clinical Potential of Breath Analysis for Disease Diagnosis and Monitoring–Tutorial , 2012, IEEE Sensors Journal.

[10]  Raed A Dweik,et al.  The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity , 2011, Journal of breath research.

[11]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[12]  R. Dweik,et al.  Clinical applications of breath testing , 2010, F1000 medicine reports.

[13]  P. V. van Rheenen,et al.  Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis , 2010, BMJ : British Medical Journal.

[14]  D. B. Milligan,et al.  Application of selected ion flow tube mass spectrometry to real-time atmospheric monitoring. , 2010, Rapid communications in mass spectrometry : RCM.

[15]  Raed A Dweik,et al.  Exhaled breath analysis: The new interface between medicine and engineering. , 2009, Advanced powder technology : the international journal of the Society of Powder Technology, Japan.

[16]  Raed A Dweik,et al.  Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications , 2008, Journal of breath research.

[17]  B. Ross,et al.  Sub-parts per billion detection of trace volatile chemicals in human breath using Selected Ion Flow Tube Mass Spectrometry , 2008, BMC Research Notes.

[18]  A. Michalsen,et al.  Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices , 2008, The American Journal of Gastroenterology.

[19]  G. Lichtenstein.  Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study , 2008 .

[20]  P. Rutgeerts,et al.  Laboratory markers in IBD: useful, magic, or unnecessary toys? , 2006, Gut.

[21]  David Smith,et al.  Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. , 2005, Mass spectrometry reviews.

[22]  E. Loftus.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[23]  T. Risby,et al.  Clinical application of breath biomarkers of oxidative stress status. , 1999, Free radical biology & medicine.

[24]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[25]  E. Yasugi,et al.  Phospholipid turnover in the inflamed intestinal mucosa: Arachidonic acid-rich phosphatidyl/plasmenyl-ethanolamine in the mucosa in inflammatory bowel disease , 1999, Journal of Gastroenterology.

[26]  R. Nelson,et al.  Determination of inflammatory bowel disease activity by breath pentane analysis , 1993, Diseases of the colon and rectum.

[27]  J T Boyle,et al.  Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.